Skip to main content
Fig. 4 | Clinical Sarcoma Research

Fig. 4

From: Treatment of gastrointestinal tumor (GIST) of the rectum requiring abdominoperineal resection following neoadjuvant imatinib: a cost-effectiveness analysis

Fig. 4

Two way sensitivity analysis comparing the net monetary benefit (NMB) of UAPR vs CIUP at a willingness to pay of SGD 50,000 when simultaneously considering varying values of utility associated with abdominoperineal resection and annual recurrence probabilities post abdominoperineal resection. Red denotes UAPR having superior NMB, while blue denotes CIUP having superior NMB

Back to article page

Clinical Sarcoma Research

ISSN: 2045-3329